Corrigendum to: CYP2B6 genotype and weight gain differences between dolutegravir and efavirenz. Griesel, R., Maartens, G., Chirehwa, M., Sokhela, S., Akpomiemie, G., Moorhouse, M., Venter, F., & Sinxadi, P. Clinical Infectious Diseases, 73(11):e3902–e3909, Oxford University Press (OUP), jan, 2021.
Corrigendum to: CYP2B6 genotype and weight gain differences between dolutegravir and efavirenz [link]Paper  doi  bibtex   
@article{Griesel2021b,
author = {Griesel, Rulan and Maartens, Gary and Chirehwa, Maxwell and Sokhela, Simiso and Akpomiemie, Godspower and Moorhouse, Michelle and Venter, Francois and Sinxadi, Phumla},
doi = {10.1093/CID/CIAB804},
file = {:C$\backslash$:/Users/01462563/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Griesel et al. - 2021 - Corrigendum to CYP2B6 genotype and weight gain differences between dolutegravir and efavirenz.pdf:pdf},
issn = {1058-4838},
journal = {Clinical Infectious Diseases},
keywords = {OA,erratum{\_}corrigendum},
mendeley-tags = {OA,erratum{\_}corrigendum},
month = {jan},
number = {11},
pages = {e3902--e3909},
pmid = {35099526},
publisher = {Oxford University Press (OUP)},
title = {{Corrigendum to: CYP2B6 genotype and weight gain differences between dolutegravir and efavirenz}},
url = {https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab804/6517845},
volume = {73},
year = {2021}
}

Downloads: 0